Genesis HealthCare (GEN) Tops Q3 EPS by 1c; offers guidance

Genesis HealthCare (NASDAQ: GEN) reported Q3 EPS of $0.56, $0.01 better than the analyst estimate of $0.55. Revenue for the quarter came in at $986 million versus the consensus estimate of $985.11 million.

GUIDANCE:

Genesis HealthCare sees Q4 2025 EPS of $0.57-$0.59, versus the consensus of $0.58. Genesis HealthCare sees Q4 2025 revenue of $990-1005 million, versus the consensus of $997.3 million.

Genesis HealthCare sees FY2025 EPS of $2.20-$2.22, versus the consensus of $2.20. Genesis HealthCare sees FY2025 revenue of $3.915-3.93 billion, versus the consensus of $3.922 billion.

For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Nutrien warns shareholders about below-market mini-tender offer
• 22nd Century Group files prospectus for warrant share resale